Fig. 3From: Safety and efficacy of elagolix (with and without add-back therapy) for the treatment of heavy menstrual bleeding associated with uterine leiomyomas: a systematic review and meta-analysisForest plots comparing: a suppression of bleeding and b amenorrhea, across treatmentsBack to article page